Skip to main content
. 2020 Jul 8;37(8):3606–3618. doi: 10.1007/s12325-020-01419-6

Table 2.

Participant baseline demographics, clinical characteristics, and myelosuppression

Breast cancer Lung cancer Colorectal cancer Total
Patients, n 153 100 48 301
Gender, n (%)
 Male 21 (14) 67 (67) 32 (67) 120 (40)
 Female 132 (86) 33 (33) 15 (31) 180 (60)
 Other 0 0 1 (2) 1 (< 1)
Age group, years, n (%)
 18–59 134 (88) 75 (75) 32 (67) 241 (80)
 ≥ 60 19 (12) 25 (25) 16 (33) 60 (20)
Currently working (full or part time), n (%) 92 (60) 65 (65) 24 (50) 181 (60)
Years since cancer diagnosis, n (%)
 < 1 37 (24) 19 (19) 11 (23) 67 (22)
 1–3 75 (49) 53 (53) 29 (60) 157 (52)
 ≥ 4 40 (26) 28 (28) 8 (17) 76 (25)
 Not answered 1 (1) 0 (0) 0 (0) 1 (< 1)
Myelosuppression, n (%)a
 Anemia 103 (67) 51 (51) 30 (63) 184 (61)
 Neutropenia 80 (52) 61 (61) 37 (77) 178 (59)
 Lymphopenia 56 (37) 32 (32) 24 (50) 112 (37)
 Thrombocytopenia 47 (31) 36 (36) 18 (38) 101 (34)

aParticipants could select more than one option